I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Status of dermal lesions in PKDL cases following treatment ..:
Shilpa Sengupta (11675550)
;
Mitali Chatterjee (323464)
https://figshare.com/articles/figure/Status_of_dermal_lesions_in_PKDL_cases_following_treatment_with_Miltefosine_or_LAmB_/16984113. , 2021
Link:
https://doi.org/10.1371/journal.pntd.0009906.g006
RT Journal T1
Status of dermal lesions in PKDL cases following treatment with Miltefosine or LAmB
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16984113&Exemplar=1&LAN=DE A1 Shilpa Sengupta (11675550) A1 Mitali Chatterjee (323464) YR 2021 K1 Biochemistry K1 Molecular Biology K1 Biotechnology K1 Immunology K1 Developmental Biology K1 Cancer K1 Infectious Diseases K1 Virology K1 non invasive alternative K1 azar dermal leishmaniasis K1 levels remained unchanged K1 cure &# 8217 K1 pkdl ) K1 especially K1 liposomal amphotericin b K1 least six months K1 monitoring therapeutic effectiveness K1 six months K1 &# 8216 K1 xlink "> K1 study explored K1 prognostic potential K1 post kala K1 markers substantially K1 major contributors K1 macular form K1 leishmanial immunoglobulin K1 ig levels K1 estimating anti K1 effective predictors K1 effective biomarkers K1 disease presentation K1 chemotherapeutic responses K1 3 weeks K1 12 weeks JF https://figshare.com/articles/figure/Status_of_dermal_lesions_in_PKDL_cases_following_treatment_with_Miltefosine_or_LAmB_/16984113 LK http://dx.doi.org/https://doi.org/10.1371/journal.pntd.0009906.g006 DO https://doi.org/10.1371/journal.pntd.0009906.g006 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)